<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/99A20F70-F6B7-43DE-94E4-7004FAE6291E"><gtr:id>99A20F70-F6B7-43DE-94E4-7004FAE6291E</gtr:id><gtr:name>Ludwig Maximilians University Munich</gtr:name><gtr:address><gtr:line1>Geschwister-Scholl-Platz 1</gtr:line1><gtr:postCode>D-80539</gtr:postCode><gtr:region>Outside UK</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/4A9426E3-7F35-48FC-BD72-3776C8F90A4A"><gtr:id>4A9426E3-7F35-48FC-BD72-3776C8F90A4A</gtr:id><gtr:name>Grants Admin Office</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/D5FA451D-4FA7-423E-93F8-046141371F35"><gtr:id>D5FA451D-4FA7-423E-93F8-046141371F35</gtr:id><gtr:name>University of Western Australia</gtr:name><gtr:address><gtr:line1>35 Stirling Highway</gtr:line1><gtr:line4>Crawley</gtr:line4><gtr:line5>WA 6009</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>Australia</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/9C10D78F-6430-4CA7-9528-B96B0762A4C6"><gtr:id>9C10D78F-6430-4CA7-9528-B96B0762A4C6</gtr:id><gtr:name>Cardiff University</gtr:name><gtr:department>School of Medicine</gtr:department><gtr:address><gtr:line1>Research &amp; Consultancy</gtr:line1><gtr:line2>PO Box 923</gtr:line2><gtr:line4>Cardiff</gtr:line4><gtr:line5>South Glamorgan</gtr:line5><gtr:postCode>CF10 3TE</gtr:postCode><gtr:region>Wales</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/9C10D78F-6430-4CA7-9528-B96B0762A4C6"><gtr:id>9C10D78F-6430-4CA7-9528-B96B0762A4C6</gtr:id><gtr:name>Cardiff University</gtr:name><gtr:address><gtr:line1>Research &amp; Consultancy</gtr:line1><gtr:line2>PO Box 923</gtr:line2><gtr:line4>Cardiff</gtr:line4><gtr:line5>South Glamorgan</gtr:line5><gtr:postCode>CF10 3TE</gtr:postCode><gtr:region>Wales</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role><gtr:role><gtr:name>FELLOW</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/99A20F70-F6B7-43DE-94E4-7004FAE6291E"><gtr:id>99A20F70-F6B7-43DE-94E4-7004FAE6291E</gtr:id><gtr:name>Ludwig Maximilians University Munich</gtr:name><gtr:address><gtr:line1>Geschwister-Scholl-Platz 1</gtr:line1><gtr:postCode>D-80539</gtr:postCode><gtr:region>Outside UK</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/4A9426E3-7F35-48FC-BD72-3776C8F90A4A"><gtr:id>4A9426E3-7F35-48FC-BD72-3776C8F90A4A</gtr:id><gtr:name>Grants Admin Office</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/D5FA451D-4FA7-423E-93F8-046141371F35"><gtr:id>D5FA451D-4FA7-423E-93F8-046141371F35</gtr:id><gtr:name>University of Western Australia</gtr:name><gtr:address><gtr:line1>35 Stirling Highway</gtr:line1><gtr:line4>Crawley</gtr:line4><gtr:line5>WA 6009</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>Australia</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/6A13EEB6-CE77-4762-B504-BA80CB101B1A"><gtr:id>6A13EEB6-CE77-4762-B504-BA80CB101B1A</gtr:id><gtr:firstName>James Tynan Rhys</gtr:firstName><gtr:surname>Walters</gtr:surname><gtr:roles><gtr:role><gtr:name>FELLOW</gtr:name></gtr:role><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G0601635"><gtr:id>49C51FCA-0C40-4745-B27E-E6C3FEE7F67C</gtr:id><gtr:title>Genetic susceptibility to a deficit in context processing across the schizophrenia / bipolar disorder diagnostic divide.</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Fellowship</gtr:grantCategory><gtr:grantReference>G0601635</gtr:grantReference><gtr:abstractText>Schizophrenia and bipolar disorder are debilitating mental illnesses which affect around 2% of the population. Research suggests that deficits in higher mental processes (cognition) are common to schizophrenia and bipolar disorder. Several genes that increase risk for schizophrenia also increase risk for bipolar disorder. These findings reflect clinical experience where many patients present with symptoms of both disorders and suggest it may be more productive to study people with symptoms of both disorders rather than separately as is the tendency in current research.
This project, conducted by a research psychiatrist, aims to examine a facet of cognition, context processing; the ability to notice the setting in which an event occurs. Using a novel test context processing will be investigated in people with symptoms of both schizophrenia and bipolar disorder. Two risk genes for schizophrenia and bipolar disorder will be investigated to see it they predict performance on the test.
If people with schizophrenia AND bipolar disorder show this cognitive deficit and the risk genes increase the chances of showing such deficits this will have implications for the classification of these mental disorders as well as informing research into the causes and potential treatment of these deficits in severe mental illness.</gtr:abstractText><gtr:technicalSummary>Background and Aims
Schizophrenia and bipolar disorder are debilitating mental illnesses which affect around 2% of the population. This project aims to build on emerging research in the fields of genetics and neurocognition which suggest a significant overlap between these two conditions. 
A range of impairments in cognitive function are evident in both schizophrenia and bipolar disorder. Context processing is an explanatory model which posits that an inability to maintain or use contextual information is responsible for many of the deficits seen in schizophrenia and bipolar disorder.
As well as being important determinants of functional outcome such neurocognitive deficits are seen as potentially valuable in dissecting the genotype/phenotype relationship of these disorders. Several candidate risk genes for schizophrenia and bipolar disorder, such as DISC1 and dysbindin, seem to confer susceptibility to a phenotype which straddles the traditional schizophrenia/bipolar diagnostic divide. By examining how these risk genes influence susceptibility to specific cognitive deficits in schizophrenia and bipolar disorder this project aims to inform the debate regarding the genotype/phenotype relationship of these disorders.
Specifically this project aims to show that a deficit in context processing, as measured by a novel test, is evident across the schizophrenia/bipolar divide and that this deficit is associated with DISC-1 and dysbindin risk alleles/haplotypes. The project also aims to investigate the relationship between these cognitive deficits and measures of psychopathology.
The project will also further develop the utility of animal genetic models of mental illness, an area which has been seen as key in advancing knowledge of mental illnesses. 
Study Design and Methodology
Context processing will be investigated using a novel test in a population with symptoms of schizophrenia and bipolar disorder. The nature of this deficit will be explored by correlation with measures of psychopathology and a comprehensive battery testing separable neurocognitive domains.
The second phase of the project will investigate whether mouse models of these susceptibility genes exhibit deficits in contextual processing use an animal analogue of the novel test.
Scientific and Medical Opportunities
This project offers a unique opportunity to examine neurocognitive deficits in relation to domains of psychopathology across the schizophrenia/bipolar divide rather than recruiting on the basis of diagnosis. Given the arguments presented above this approach may offer advantages in elucidating the pathways between genes and mental illnesses as well as informing debates about classification, diagnosis and potential treatment approaches.</gtr:technicalSummary><gtr:fund><gtr:end>2010-09-30</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2007-10-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>270733</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>Ludwig Maximilian University of Munich (LMU Munich)</gtr:collaboratingOrganisation><gtr:country>Germany, Federal Republic of</gtr:country><gtr:department>Clinic of Psychiatry</gtr:department><gtr:description>Cognition and genetics in Schizophrenia</gtr:description><gtr:id>A6B3C735-E002-4932-A57B-32AA87EFE54E</gtr:id><gtr:impact>this collaboration seeks to examine the impact of schizophrenia susceptibility on aspects of cognition and provide insights into common pathways between schizophrenia and cognitive deficits</gtr:impact><gtr:outcomeId>eJp8F3UMkSx-1</gtr:outcomeId><gtr:partnerContribution>Provide dataJoint papersprovide data</gtr:partnerContribution><gtr:piContribution>Analysis of Data
Joint Papers</gtr:piContribution><gtr:sector>Hospitals</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Ludwig Maximilian University of Munich (LMU Munich)</gtr:collaboratingOrganisation><gtr:country>Germany, Federal Republic of</gtr:country><gtr:department>Department of Psychiatry and Psychotherapy</gtr:department><gtr:description>Prof Dan Rujescu</gtr:description><gtr:id>CE178D4A-B30D-4812-AFFC-FDAEB3967705</gtr:id><gtr:impact>Ongoing access and collaboration Publications - 2 papers in Archives of General Psychiatry</gtr:impact><gtr:outcomeId>FE22DD26A22-1</gtr:outcomeId><gtr:partnerContribution>access to data on large clinical and control populations</gtr:partnerContribution><gtr:piContribution>We have provided genotyping and analysis as well as experimental design.</gtr:piContribution><gtr:sector>Hospitals</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Trinity College Dublin</gtr:collaboratingOrganisation><gtr:country>Ireland, Republic of</gtr:country><gtr:description>Dr Gary Donohoe</gtr:description><gtr:id>16BA61F7-05B7-4271-AB70-8A80E9407B81</gtr:id><gtr:impact>2 papers (one in press) in Archives of General Psychiatry Papers - 19805695, and article in press, The psychosis susceptibility gene ZNF804A is associated with less impaired cognitive performance in schizophrenia.</gtr:impact><gtr:outcomeId>898C2FA8499-1</gtr:outcomeId><gtr:partnerContribution>Help with analysis and together replicating results resulting in 2 high impact publications in the last year.</gtr:partnerContribution><gtr:piContribution>See above</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Trinity College Dublin</gtr:collaboratingOrganisation><gtr:country>Ireland, Republic of</gtr:country><gtr:description>Cognition and genetics in Schizophrenia</gtr:description><gtr:id>23B93A05-2D0B-4171-B038-8A9F24A92DF3</gtr:id><gtr:impact>this collaboration seeks to examine the impact of schizophrenia susceptibility on aspects of cognition and provide insights into common pathways between schizophrenia and cognitive deficits</gtr:impact><gtr:outcomeId>eJp8F3UMkSx-2</gtr:outcomeId><gtr:partnerContribution>Provide dataJoint papersprovide data</gtr:partnerContribution><gtr:piContribution>Analysis of Data
Joint Papers</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Western Australia</gtr:collaboratingOrganisation><gtr:country>Australia, Commonwealth of</gtr:country><gtr:description>Cognition and genetics in Schizophrenia</gtr:description><gtr:id>BE664BB9-EDB6-4E63-954A-473DACB91ABF</gtr:id><gtr:impact>this collaboration seeks to examine the impact of schizophrenia susceptibility on aspects of cognition and provide insights into common pathways between schizophrenia and cognitive deficits</gtr:impact><gtr:outcomeId>eJp8F3UMkSx-3</gtr:outcomeId><gtr:partnerContribution>Provide dataJoint papersprovide data</gtr:partnerContribution><gtr:piContribution>Analysis of Data
Joint Papers</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>ZNF804A, the top hit in Schizophrenia GWAS studies to date, is associated with cognitive function in Schizophrenia cases and controls</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>3A337520-6F39-4986-9FC1-7CE1029EB7CC</gtr:id><gtr:impact>International Congress of Schizophrenia Research, San Diego


this collaboration seeks to examine the impact of schizophrenia susceptibility on aspects of cognition and provide insights into common pathways between schizophrenia and cognitive deficits</gtr:impact><gtr:outcomeId>TAxY5k7xK97</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:year>2009</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Follow-Up of Schizophrenia GWAS implicates MHC in cognition</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>9583CC8A-8970-4971-B3E3-D7C439896DB7</gtr:id><gtr:impact>A poster presentation at the International Society of Psychiatric Genetics, Washington


this collaboration seeks to examine the impact of schizophrenia susceptibility on aspects of cognition and provide insights into common pathways between schizophrenia and cognitive deficits</gtr:impact><gtr:outcomeId>p9bVzAwxrwV</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>newsletter</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>0A9C9DF2-61DC-41AF-8026-BCD636F0CDCB</gtr:id><gtr:impact>A research team newsletter was sent out to around 400 participants and a further 200 health professionals/organisations that have helped with recruitment for this fellowship project over the last 3 years.

Further collaboration with voluntary mental health organisation Hafal resulted form teh above.</gtr:impact><gtr:outcomeId>L7CRQDFJzWq</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Participants in your research and patient groups</gtr:primaryAudience><gtr:year>2010</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>5000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Seed Corn Funding for new MRC Centre for NeuroPsychiatric Genetics and Genomics</gtr:description><gtr:fundingOrg>Cardiff University</gtr:fundingOrg><gtr:id>26FBE300-B52F-47AF-B617-A283280A057D</gtr:id><gtr:outcomeId>7E5439A5AE50</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>40000</gtr:amountPounds><gtr:country>United States of America</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>NARSAD Young Investigator Award</gtr:description><gtr:fundingOrg>Autism Speaks</gtr:fundingOrg><gtr:id>0F7A06A8-0825-46CE-9EFC-A24396B6B997</gtr:id><gtr:outcomeId>9DBE738164A0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>20000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Linking cognition and genetics to dissect the mood/psychosis interface</gtr:description><gtr:end>2012-07-02</gtr:end><gtr:fundingOrg>British Medical Association (BMA)</gtr:fundingOrg><gtr:id>B79B416B-7A58-4D48-ACD2-E4BE396415A5</gtr:id><gtr:outcomeId>fB5QHHU6dSQ</gtr:outcomeId><gtr:sector>Learned Society</gtr:sector><gtr:start>2009-03-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>20000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>BMA Margaret Temple Award</gtr:description><gtr:fundingOrg>British Medical Association (BMA)</gtr:fundingOrg><gtr:id>3484674A-B501-4FBD-8A4D-0DDE2ED0BCD4</gtr:id><gtr:outcomeId>BE0F6D214220</gtr:outcomeId><gtr:sector>Learned Society</gtr:sector></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>780000</gtr:amountPounds><gtr:country>European Union (EU)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>Seventh Framework Programme (FP7)</gtr:department><gtr:description>CRESTAR - Pharmacogenomic biomarkers as clinical decision making tools for clozapine treatment of schizophrenia</gtr:description><gtr:end>2015-10-02</gtr:end><gtr:fundingOrg>European Commission</gtr:fundingOrg><gtr:id>0091620B-009F-4077-8D1D-73AB0031E9EF</gtr:id><gtr:outcomeId>mgKcfX2Hv7C</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2011-11-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>35000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Clinical Research Assistantship</gtr:description><gtr:end>2015-09-02</gtr:end><gtr:fundingOrg>Health and Care Research Wales</gtr:fundingOrg><gtr:id>5DC7E49D-476F-4248-A035-118A154916AF</gtr:id><gtr:outcomeId>PEHhJyhGLBM</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2012-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>25905</gtr:amountPounds><gtr:country>United States of America</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Schizophrehia and psychosis cognition and genetics</gtr:description><gtr:end>2018-03-02</gtr:end><gtr:fundingOrg>Brain &amp; Behaviour Research Foundation</gtr:fundingOrg><gtr:fundingRef>26420</gtr:fundingRef><gtr:id>B29ED1B0-87D9-447B-AE36-E7620BC071E0</gtr:id><gtr:outcomeId>gLW1wasM1wy</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2013-04-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>Database of genetic and phenotypic information relating to new schizophrenia samples</gtr:description><gtr:id>7C0DEDA5-2203-4561-B90D-F987D6B2734C</gtr:id><gtr:impact>Papers in progress</gtr:impact><gtr:outcomeId>A86pC6j6p78</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>Cardiff COGS</gtr:title><gtr:type>Biological samples</gtr:type></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>Database and DNA collection - 700 patient sample</gtr:description><gtr:id>6CFB1400-A0F2-47C8-B518-1C29107DC2B2</gtr:id><gtr:impact>Papers 19805695, 20603450, 20826496, 21232013, 21112188, 21283083, 21850710</gtr:impact><gtr:outcomeId>jmWFy1s8Bhp</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Cognition of Schizophrenia</gtr:title><gtr:type>Biological samples</gtr:type><gtr:yearFirstProvided>2008</gtr:yearFirstProvided></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>54D99F1F-B2CB-4FC4-851B-996524B4434A</gtr:id><gtr:title>Predicting post-traumatic stress disorder: validation of the Trauma Screening Questionnaire in victims of assault.</gtr:title><gtr:parentPublicationTitle>Psychological medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e1c8385c3f92d4be458177c66db13219"><gtr:id>e1c8385c3f92d4be458177c66db13219</gtr:id><gtr:otherNames>Walters JT</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0033-2917</gtr:issn><gtr:outcomeId>2A4104D00CA</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DFD95993-E404-4E33-B011-A82DF46C822A</gtr:id><gtr:title>A validation of cognitive biomarkers for the early identification of cognitive enhancing agents in schizotypy: a three-center double-blind placebo-controlled study.</gtr:title><gtr:parentPublicationTitle>European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/28d7a3dfce1ed86e41dbe1293fd3cc46"><gtr:id>28d7a3dfce1ed86e41dbe1293fd3cc46</gtr:id><gtr:otherNames>Koychev I</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0924-977X</gtr:issn><gtr:outcomeId>pm_14953_23_22137565</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F41CF10A-4591-458F-B209-AC8BBCAFFF68</gtr:id><gtr:title>Psychosis susceptibility gene ZNF804A and cognitive performance in schizophrenia.</gtr:title><gtr:parentPublicationTitle>Archives of general psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e1c8385c3f92d4be458177c66db13219"><gtr:id>e1c8385c3f92d4be458177c66db13219</gtr:id><gtr:otherNames>Walters JT</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0003-990X</gtr:issn><gtr:outcomeId>6C9663C2851</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D8CC4855-9F3E-4FD0-99A9-6316C658B233</gtr:id><gtr:title>The penetrance of copy number variations for schizophrenia and developmental delay.</gtr:title><gtr:parentPublicationTitle>Biological psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ad08c4bde78425a36c67533be4d81823"><gtr:id>ad08c4bde78425a36c67533be4d81823</gtr:id><gtr:otherNames>Kirov G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0006-3223</gtr:issn><gtr:outcomeId>pm_14953_23_23992924</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>60CC1464-C4EA-4714-BFA1-A1AC1BDE3D43</gtr:id><gtr:title>Neuropsychological effects of the CSMD1 genome-wide associated schizophrenia risk variant rs10503253.</gtr:title><gtr:parentPublicationTitle>Genes, brain, and behavior</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fd13d1c1642b52c119b276100b5e6476"><gtr:id>fd13d1c1642b52c119b276100b5e6476</gtr:id><gtr:otherNames>Donohoe G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1601-183X</gtr:issn><gtr:outcomeId>pm_14953_23_23320435</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>991AF433-DAD9-4214-86C1-65DF4936F71F</gtr:id><gtr:title>A neuropsychological investigation of the genome wide associated schizophrenia risk variant NRGN rs12807809.</gtr:title><gtr:parentPublicationTitle>Schizophrenia research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fd13d1c1642b52c119b276100b5e6476"><gtr:id>fd13d1c1642b52c119b276100b5e6476</gtr:id><gtr:otherNames>Donohoe G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0920-9964</gtr:issn><gtr:outcomeId>pm_14953_23_21112188</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5059621C-B179-4F41-BB0C-C52D2348A360</gtr:id><gtr:title>The role of the major histocompatibility complex region in cognition and brain structure: a schizophrenia GWAS follow-up.</gtr:title><gtr:parentPublicationTitle>The American journal of psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e1c8385c3f92d4be458177c66db13219"><gtr:id>e1c8385c3f92d4be458177c66db13219</gtr:id><gtr:otherNames>Walters JT</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0002-953X</gtr:issn><gtr:outcomeId>pm_14953_23_23903335</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E3CBEA67-0093-42CF-878C-792338B83A11</gtr:id><gtr:title>Influence of NOS1 on verbal intelligence and working memory in both patients with schizophrenia and healthy control subjects.</gtr:title><gtr:parentPublicationTitle>Archives of general psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fd13d1c1642b52c119b276100b5e6476"><gtr:id>fd13d1c1642b52c119b276100b5e6476</gtr:id><gtr:otherNames>Donohoe G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0003-990X</gtr:issn><gtr:outcomeId>64E57680C48</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DEBB0A90-3F54-416B-ABDF-8E741834694C</gtr:id><gtr:title>Clinical questions and uncertainty--prolactin measurement in patients with schizophrenia and bipolar disorder.</gtr:title><gtr:parentPublicationTitle>Journal of psychopharmacology (Oxford, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/612c8582f95e7596e12c3f768adfb8f4"><gtr:id>612c8582f95e7596e12c3f768adfb8f4</gtr:id><gtr:otherNames>Walters J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0269-8811</gtr:issn><gtr:outcomeId>862E715F88D</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>03CD1A39-1D22-4D21-A7D9-683F0E1B7FF6</gtr:id><gtr:title>An inherited duplication at the gene p21 Protein-Activated Kinase 7 (PAK7) is a risk factor for psychosis.</gtr:title><gtr:parentPublicationTitle>Human molecular genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c25d3f0c0306d2131641714db5d1e8b3"><gtr:id>c25d3f0c0306d2131641714db5d1e8b3</gtr:id><gtr:otherNames>Morris DW</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0964-6906</gtr:issn><gtr:outcomeId>54533c07f2d2c6.25955893</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>237723C2-EB9B-4D59-824C-7127868F6CF1</gtr:id><gtr:title>Genome-wide association analysis identifies 13 new risk loci for schizophrenia.</gtr:title><gtr:parentPublicationTitle>Nature genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9c8d6984e5c8a907d8380f687ccba0dd"><gtr:id>9c8d6984e5c8a907d8380f687ccba0dd</gtr:id><gtr:otherNames>Ripke S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1061-4036</gtr:issn><gtr:outcomeId>pm_14953_23_23974872</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E39B49D2-7B9E-4595-877D-E4B1982B9822</gtr:id><gtr:title>CNV analysis in a large schizophrenia sample implicates deletions at 16p12.1 and SLC1A1 and duplications at 1p36.33 and CGNL1.</gtr:title><gtr:parentPublicationTitle>Human molecular genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a6bfee0f02aa84b2b8d858dfc88f37d0"><gtr:id>a6bfee0f02aa84b2b8d858dfc88f37d0</gtr:id><gtr:otherNames>Rees E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0964-6906</gtr:issn><gtr:outcomeId>54533c08a0ddf2.73974002</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8B857F6F-A159-44FF-9229-9A95D2621C8A</gtr:id><gtr:title>Further evidence for high rates of schizophrenia in 22q11.2 deletion syndrome.</gtr:title><gtr:parentPublicationTitle>Schizophrenia research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2f46c6bf4a424e9bee50e4e57e46d329"><gtr:id>2f46c6bf4a424e9bee50e4e57e46d329</gtr:id><gtr:otherNames>Monks S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0920-9964</gtr:issn><gtr:outcomeId>54533c07cba084.20135611</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B0696695-28C4-41A5-9FC1-25DD08210505</gtr:id><gtr:title>Is the perimenopause a time of increased risk of recurrence in women with a history of bipolar affective postpartum psychosis? A case series.</gtr:title><gtr:parentPublicationTitle>Archives of women's mental health</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/33b45284265de97890784897429de492"><gtr:id>33b45284265de97890784897429de492</gtr:id><gtr:otherNames>Robertson Blackmore E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1434-1816</gtr:issn><gtr:outcomeId>2C8F4ACC612</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D8A5D748-B3E6-4DAE-B76E-8462D7C46542</gtr:id><gtr:title>Investigation of rare non-synonymous variants at ABCA13 in schizophrenia and bipolar disorder.</gtr:title><gtr:parentPublicationTitle>Molecular psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b37fd5287b581bf5e3a793dda319ed34"><gtr:id>b37fd5287b581bf5e3a793dda319ed34</gtr:id><gtr:otherNames>Dwyer S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1359-4184</gtr:issn><gtr:outcomeId>pm_14953_23_21283083</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>56EB71E5-9419-4E5D-B212-67D7CE9F3CD1</gtr:id><gtr:title>Steroid sulfatase is a potential modifier of cognition in Attention Deficit Hyperactivity Disorder</gtr:title><gtr:parentPublicationTitle>Genes, Brain and Behavior</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/90ee33f608de0da32ce499f2d9f707f0"><gtr:id>90ee33f608de0da32ce499f2d9f707f0</gtr:id><gtr:otherNames>Stergiakouli E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:outcomeId>pm_14953_23_21232013</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6438015C-C57E-4DE5-9599-C00F411C5EB8</gtr:id><gtr:title>Steroid sulfatase is a potential modifier of cognition in attention deficit hyperactivity disorder.</gtr:title><gtr:parentPublicationTitle>Genes, brain, and behavior</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/90ee33f608de0da32ce499f2d9f707f0"><gtr:id>90ee33f608de0da32ce499f2d9f707f0</gtr:id><gtr:otherNames>Stergiakouli E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1601-183X</gtr:issn><gtr:outcomeId>pm_14953_23_21255266</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>447AF91F-79B0-439C-8E44-70B8982F85C0</gtr:id><gtr:title>A rare variant in APOC3 is associated with plasma triglyceride and VLDL levels in Europeans.</gtr:title><gtr:parentPublicationTitle>Nature communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fb989445f5f5ea04945f0fe570b9dcf9"><gtr:id>fb989445f5f5ea04945f0fe570b9dcf9</gtr:id><gtr:otherNames>Timpson NJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>2041-1723</gtr:issn><gtr:outcomeId>56c318704653b9.00866542</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>63438BFC-7AB0-4093-90AD-20D780296BAC</gtr:id><gtr:title>Wake-up call for British psychiatry.</gtr:title><gtr:parentPublicationTitle>The British journal of psychiatry : the journal of mental science</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9f1fd8cf35c36a483c821f0ab45ecde4"><gtr:id>9f1fd8cf35c36a483c821f0ab45ecde4</gtr:id><gtr:otherNames>Craddock N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0007-1250</gtr:issn><gtr:outcomeId>FD587F0A3EC</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>386158C8-09CA-4B18-90B9-49AD2CBA38D8</gtr:id><gtr:title>Sub-threshold manic symptoms in recurrent major depressive disorder are a marker for poor outcome.</gtr:title><gtr:parentPublicationTitle>Acta psychiatrica Scandinavica</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/451acd90e2ce7f931e27365f5cc23fb8"><gtr:id>451acd90e2ce7f931e27365f5cc23fb8</gtr:id><gtr:otherNames>Smith DJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0001-690X</gtr:issn><gtr:outcomeId>0F59C6CF2E8</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F82D5D6D-E3F0-4A33-A4F2-148B1AB383FD</gtr:id><gtr:title>Biological insights from 108 schizophrenia-associated genetic loci.</gtr:title><gtr:parentPublicationTitle>Nature</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5e1bb4de5fe4e3c021f29fe2b4f1a77e"><gtr:id>5e1bb4de5fe4e3c021f29fe2b4f1a77e</gtr:id><gtr:otherNames>Schizophrenia Working Group of the Psychiatric Genomics Consortium</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0028-0836</gtr:issn><gtr:outcomeId>54533c075106b1.05140008</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>751501CB-1778-46A6-BF32-4C8BBF66A30B</gtr:id><gtr:title>Partitioning heritability of regulatory and cell-type-specific variants across 11 common diseases.</gtr:title><gtr:parentPublicationTitle>American journal of human genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7d00927a64f1f34d88638bf3dd2d3f8c"><gtr:id>7d00927a64f1f34d88638bf3dd2d3f8c</gtr:id><gtr:otherNames>Gusev A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0002-9297</gtr:issn><gtr:outcomeId>56c31870207e59.37515582</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>31334DF4-B287-45E2-AA9F-32AEA338FF25</gtr:id><gtr:title>Mutation screening of the 3q29 microdeletion syndrome candidate genes DLG1 and PAK2 in schizophrenia.</gtr:title><gtr:parentPublicationTitle>American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/29c66dc719ce51792539e87f87c697b2"><gtr:id>29c66dc719ce51792539e87f87c697b2</gtr:id><gtr:otherNames>Carroll LS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1552-4841</gtr:issn><gtr:outcomeId>pm_14953_23_21850710</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>89817EC2-38BC-49C4-BCAA-A1DE2306B8D1</gtr:id><gtr:title>Evidence that duplications of 22q11.2 protect against schizophrenia.</gtr:title><gtr:parentPublicationTitle>Molecular psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a6bfee0f02aa84b2b8d858dfc88f37d0"><gtr:id>a6bfee0f02aa84b2b8d858dfc88f37d0</gtr:id><gtr:otherNames>Rees E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1359-4184</gtr:issn><gtr:outcomeId>54533c0873d7c4.00322761</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>83EE5BFA-E11F-46AA-A933-638332BEE246</gtr:id><gtr:title>Genome-wide significant associations in schizophrenia to ITIH3/4, CACNA1C and SDCCAG8, and extensive replication of associations reported by the Schizophrenia PGC.</gtr:title><gtr:parentPublicationTitle>Molecular psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3b2aaf1b7109ac42d9d9d55641e4ae7f"><gtr:id>3b2aaf1b7109ac42d9d9d55641e4ae7f</gtr:id><gtr:otherNames>Hamshere ML</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1359-4184</gtr:issn><gtr:outcomeId>pm_14953_23_22614287</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BF356159-D549-4155-AF2A-ACE33D0DE2A7</gtr:id><gtr:title>Authors' reply.</gtr:title><gtr:parentPublicationTitle>The British journal of psychiatry : the journal of mental science</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a6bfee0f02aa84b2b8d858dfc88f37d0"><gtr:id>a6bfee0f02aa84b2b8d858dfc88f37d0</gtr:id><gtr:otherNames>Rees E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0007-1250</gtr:issn><gtr:outcomeId>54533c077dda24.52150167</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1E54094A-D15C-44D1-B9D1-F8470E309DA4</gtr:id><gtr:title>The effects of ketamine and risperidone on eye movement control in healthy volunteers.</gtr:title><gtr:parentPublicationTitle>Translational psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/94f4449077a1b233b795dbfdf1b71e87"><gtr:id>94f4449077a1b233b795dbfdf1b71e87</gtr:id><gtr:otherNames>Schmechtig A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>2158-3188</gtr:issn><gtr:outcomeId>54533c082731b7.48058028</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A6BEBE48-B2E7-4BC8-A1B5-428DF2CD49A2</gtr:id><gtr:title>Differences in depressive symptom profile between males and females.</gtr:title><gtr:parentPublicationTitle>Journal of affective disorders</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/451acd90e2ce7f931e27365f5cc23fb8"><gtr:id>451acd90e2ce7f931e27365f5cc23fb8</gtr:id><gtr:otherNames>Smith DJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0165-0327</gtr:issn><gtr:outcomeId>C15C61658D6</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>735DFD8F-7DD1-442D-8837-AB44F37D2213</gtr:id><gtr:title>Defective processing speed and nonclinical psychotic experiences in children: longitudinal analyses in a large birth cohort.</gtr:title><gtr:parentPublicationTitle>The American journal of psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e38c31bba50b03219bee54d055a6d1d0"><gtr:id>e38c31bba50b03219bee54d055a6d1d0</gtr:id><gtr:otherNames>Niarchou M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0002-953X</gtr:issn><gtr:outcomeId>pm_14953_23_23632836</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>34B0B5BD-F66E-449E-8252-F2202DE25857</gtr:id><gtr:title>The health informatics cohort enhancement project (HICE): using routinely collected primary care data to identify people with a lifetime diagnosis of psychotic disorder.</gtr:title><gtr:parentPublicationTitle>BMC research notes</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d65674489b2b9f1046ad0c915c2684df"><gtr:id>d65674489b2b9f1046ad0c915c2684df</gtr:id><gtr:otherNames>Economou A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1756-0500</gtr:issn><gtr:outcomeId>pm_14953_23_22333117</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>02772320-7D24-4E4F-90B3-7835E8FE5206</gtr:id><gtr:title>A survey of verbal and physical assaults towards psychiatrists in Turkey.</gtr:title><gtr:parentPublicationTitle>The International journal of social psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8e475012897440f960ccb97311f260f8"><gtr:id>8e475012897440f960ccb97311f260f8</gtr:id><gtr:otherNames>Altinbas K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0020-7640</gtr:issn><gtr:outcomeId>BqhTdznFgn5</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>72F1C82C-8C59-46B4-996E-EFE87CD1F3A4</gtr:id><gtr:title>Analysis of copy number variations at 15 schizophrenia-associated loci.</gtr:title><gtr:parentPublicationTitle>The British journal of psychiatry : the journal of mental science</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a6bfee0f02aa84b2b8d858dfc88f37d0"><gtr:id>a6bfee0f02aa84b2b8d858dfc88f37d0</gtr:id><gtr:otherNames>Rees E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0007-1250</gtr:issn><gtr:outcomeId>54533c084e3b48.73476327</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1CF5F125-6C42-46E4-807A-3A5F99393C00</gtr:id><gtr:title>Copy number variation in schizophrenia in Sweden.</gtr:title><gtr:parentPublicationTitle>Molecular psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/75e3946c366e47f3ae2176d9c187f7ec"><gtr:id>75e3946c366e47f3ae2176d9c187f7ec</gtr:id><gtr:otherNames>Szatkiewicz JP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1359-4184</gtr:issn><gtr:outcomeId>54533c07a59da2.25469315</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0601635</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>3C193D18-12BD-4B15-8347-037BA623E0FF</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Mental Health</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>